Skip to main content
OpenTrials
Completed

NCT Number: NCT05306106

Glycemic Index of Pastry

In the early 1980s and following the first publications by Jenkins et al., The notion of glycemic index (GI) appeared with the aim of classifying the different sources of carbohydrates in our diet according to their effect on the post-prandial glycemic response. Since these years, many studies have been designed to determine the usefulness of the glycemic index and indicate that a low glycemic index for a food, a dish, a meal or a diet is associated with a decreased risk of metabolic pathologies (diabetes, hypertriglyceridemia), degenerative (cardiovascular diseases) or overload (obesity). This justifies the interest in favoring foods with a low glycemic index in healthy subjects.

A review confirmed the mechanistic link between postprandial blood sugar and the variability of blood sugar, making it possible, on the one hand, to maintain good glucose homeostasis and, on the other hand, to prevent pathologies such as obesity, diabetes and cardio-vascular diseases. The EFSA also considers that reducing the increase in blood sugar in the post-meal phase can be considered a physiological benefit, especially in subjects with glucose intolerance.

Post-meal blood sugar depends on many factors including the glycemic index of foods eaten during the meal. Knowing the glycemic index of foods is therefore very useful.

Mademoiselle Dessert offers pastries with a low glycemic index. The objective of this study is thus to determine the glycemic index of 6 pastries in order to inform consumers on these pastries glycemic index.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Volunteers

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NutrInvest - Institut Pasteur de Lille

Lille, Nord, 59019, France

About this study

The study will be carried out on healthy volunteers, aged from 18 to 65 with a body mass index (BMI) between 18 and 30 kg/m² (limits included).

The main objective of the study is to determine the glycemic index of 6 pastries in healthy volunteers with 7 kinetic points (0, 15, 30, 45, 60, 90 and 120 min).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Man or woman ;
  • Aged 18 to 65 (limits included);
  • Having a body mass index (BMI) between 18 and 30 kg / m² (limits included);
  • Agreeing to maintain their lifestyle (sport and diet) for the duration of the study;
  • Agreeing not to smoke on the morning of each visit (before and during the visit).

Exclusion criteria

  • Fasting blood glucose ≥ 6.1 mmol / L (or 1.10 g / L);
  • Fasting triglycerides ˃ 2 g / L;
  • Hyperinsulinemia (20 mIU / L) or history of insulinoma;
  • Elevation of transaminases beyond 2x the upper limit;
  • Subject presenting episodes of functional post-meal hypoglycaemia;
  • Diabetic subject whether or not treated;
  • Subject suffering from a severe eating disorder (anorexia, bulimia, binge eating);
  • Subject presenting an immunodeficiency or any other serious pathology (cancer, hemopathy);
  • Subject with a history of hypercholesterolemia and high blood pressure;
  • Subject with renal failure;
  • Subject with an allergy / intolerance to one of the constituents of the products under study;
  • Subject with an intestinal pathology likely to modify digestion or absorption (Crohn's disease, etc.);
  • Subject consuming more than 3 glasses of alcohol per day for men and more than 2 glasses per day for women;
  • Subject not having a stable weight for the last 3 months (± 5%);
  • Woman pregnant or planning to be during the study period, breastfeeding woman.

Treatment and study plan

Glucose

Other

Each subject will consume the reference product during visits V1 and V5. A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume the glucose solution. The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

truffle match

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 221.2 g of truffle match (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

hazelnut chocolate cookie

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 142.8 g of hazelnut chocolate cookie (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

Paris Brest style eclair

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 277.7 g of Paris Brest style eclair (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

hazelnut chocolate finger

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 312.5 g of hazelnut chocolate finger (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

lemon finger

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 263.1 g of lemon finger (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

elderflower madeleine

Other

The products evaluated are pastries from the Mademoiselle Desserts range. The amounts consumed will be calculated for each of the pastries so that 50 g of carbohydrate is ingested per intake. Subjects may consume 200 mL of water after ingesting the pastries. During visits V2 to V4 and V6 to V8, the subject will consume successively the pastries which will have been assigned to him randomly and according to the randomization list.

During the visit : A venous catheter will be placed by a medical biology technician and a blood sample will be taken immediately after placement: this is the first sample at T = 0 min. Then, the subject will have a maximum of 10 minutes to consume 294.1 g of elderflower madeleine (contained 50 g of glucose). The technician will then take blood samples at T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 minutes.

Primary outcomes

  1. Glycemia: 7-point kinetics

    Time frame: 0 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  2. Glycemia: 7-point kinetics

    Time frame: 15 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  3. Glycemia: 7-point kinetics

    Time frame: 30 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  4. Glycemia: 7-point kinetics

    Time frame: 45 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  5. Glycemia: 7-point kinetics

    Time frame: 60 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  6. Glycemia: 7-point kinetics

    Time frame: 90 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

  7. Glycemia: 7-point kinetics

    Time frame: 120 min

    Blood glucose kinetics over 2 hours, performed from 7 blood samples and at 7 different times: T = 0, T = 15, T = 30, T = 45, T = 60, T = 90 and T = 120 min, on each test product and on the reference product (glucose).

    Visits V1 to V8

Secondary outcomes

  1. Peak blood sugar (Cmax-Gly)

    Time frame: 0, 15, 30, 45, 60, 90 and 120 min

    For each product and from the glycemia and insulinemia dosage curves: peak blood sugar (Cmax-Gly).

    Visits V1 to V8

  2. The time to onset of the blood sugar peak (Tmax-Gly)

    Time frame: 0, 15, 30, 45, 60, 90 and 120 min

    For each product and from the glycemia and insulinemia dosage curves: the time to onset of the blood sugar peak (Tmax-Gly). Visits V1 to V8

  3. Insulin index

    Time frame: 0, 15, 30, 45, 60, 90 and 120 min

    For each product and from the glycemia and insulinemia dosage curves: insulin index Visits V1 to V8

  4. Peak insulinemia (Cmax-Ins)

    Time frame: 0, 15, 30, 45, 60, 90 and 120 min

    For each product and from the glycemia and insulinemia dosage curves: peak insulinemia (Cmax-Ins).

    Visits V1 to V8

  5. The time to onset of peak insulinemia (Tmax-Ins)

    Time frame: 0, 15, 30, 45, 60, 90 and 120 min

    For each product and from the glycemia and insulinemia dosage curves: the time to onset of peak insulinemia (Tmax-Ins). Visits V1 to V8

Sponsors and collaborators

Lead sponsor

Institut Pasteur de Lille

Other

Registry information

Official study title

Determination of the Glycemic Index of Pastry. A Randomized Study on Healthy Volunteers.

Acronym: IG-DESSERT

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 31, 2022
Registry last updated
Mar 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.